💨 Abstract
Milestone Pharmaceuticals Inc. reported a $20.8 million loss (31 cents per share) in the first quarter of 2025, exceeding analysts' expectations of a 19 cents per share loss. This announcement was made on Wednesday, May 14, 2025.
Courtesy: wtop.com
Suggested
Trump budget cuts could push DC area into a recession, George Mason professor says -
European Council president Costa praises Montenegro’s advance on EU path -
EPA announces rollback for some Biden-era limits on so-calledforever chemicals in drinking water -
EPA plans to drop limits on some ‘forever chemicals’ in drinking water while keeping standards on two common types -
SuperCom: Q1 Earnings Snapshot -
Neonode: Q1 Earnings Snapshot -
Coco Gauff advances to Italian Open semifinals with straight-set win over Mirra Andreeva -
Merz vows to keep the US on board on Ukraine and strengthen Germany’s military and economy -
‘All kinds of nutty about climate.’ New York’s Rochester draws residents fleeing extreme weather -
California governor proposes pausing expansion of health care to low-income immigrants -